Jonathan Diver

594 total citations
14 papers, 479 citations indexed

About

Jonathan Diver is a scholar working on Molecular Biology, Molecular Medicine and Pharmacology. According to data from OpenAlex, Jonathan Diver has authored 14 papers receiving a total of 479 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Molecular Medicine and 5 papers in Pharmacology. Recurrent topics in Jonathan Diver's work include Cancer therapeutics and mechanisms (6 papers), Antibiotic Resistance in Bacteria (6 papers) and Antibiotics Pharmacokinetics and Efficacy (5 papers). Jonathan Diver is often cited by papers focused on Cancer therapeutics and mechanisms (6 papers), Antibiotic Resistance in Bacteria (6 papers) and Antibiotics Pharmacokinetics and Efficacy (5 papers). Jonathan Diver collaborates with scholars based in United Kingdom, Canada and United States. Jonathan Diver's co-authors include Robert A. Wise, Laura J. V. Piddock, Tineke Schollaardt, L E Bryan, A Kureishi, Brenda Beckthold, Pamela A. Sokol, Mirianas Chachisvilis, Philippe Marchand and Norbert Hagen and has published in prestigious journals such as Blood, Clinical Infectious Diseases and Analytical Biochemistry.

In The Last Decade

Jonathan Diver

13 papers receiving 449 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jonathan Diver United Kingdom 9 240 229 147 87 62 14 479
Lisa M. Leung United States 10 221 0.9× 168 0.7× 51 0.3× 48 0.6× 39 0.6× 10 424
Anne-Marie Girard United States 14 454 1.9× 205 0.9× 350 2.4× 17 0.2× 31 0.5× 16 708
Svetlana Dubiley Russia 17 60 0.3× 460 2.0× 166 1.1× 106 1.2× 74 1.2× 38 736
Asha S. Nayar United States 7 210 0.9× 230 1.0× 79 0.5× 104 1.2× 12 0.2× 7 386
Miguel A. Alcantar United States 7 81 0.3× 347 1.5× 25 0.2× 60 0.7× 75 1.2× 9 517
Lorenz Brandstätter Switzerland 6 449 1.9× 290 1.3× 129 0.9× 196 2.3× 11 0.2× 6 695
Indran Mathavan United Kingdom 6 75 0.3× 195 0.9× 65 0.4× 37 0.4× 12 0.2× 6 328
Nathan Haseley United States 7 106 0.4× 309 1.3× 25 0.2× 94 1.1× 26 0.4× 8 572
Christopher E. Morgan United States 15 203 0.8× 346 1.5× 73 0.5× 83 1.0× 9 0.1× 23 602
Christine Sizemore United States 12 45 0.2× 295 1.3× 38 0.3× 120 1.4× 31 0.5× 23 529

Countries citing papers authored by Jonathan Diver

Since Specialization
Citations

This map shows the geographic impact of Jonathan Diver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Diver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Diver more than expected).

Fields of papers citing papers by Jonathan Diver

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan Diver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Diver. The network helps show where Jonathan Diver may publish in the future.

Co-authorship network of co-authors of Jonathan Diver

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan Diver. A scholar is included among the top collaborators of Jonathan Diver based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan Diver. Jonathan Diver is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
2.
Sigal, Darren, Jorge J. Nieva, Jonathan Diver, et al.. (2007). Significant Activity of Dasatinib in CLL Demonstrated by Ex-Vivo Assay.. Blood. 110(11). 4197–4197. 2 indexed citations
3.
Nerenberg, Michael, Ilona Kariv, Philippe Marchand, et al.. (2006). Use of optophoresis as an in vitro predictor of cell response to chemotherapy for chronic lymphocytic leukemia. Leukemia & lymphoma. 47(10). 2194–2202. 6 indexed citations
4.
Hagen, Norbert, et al.. (2004). Elastic Light Scattering from Single Cells: Orientational Dynamics in Optical Trap. Biophysical Journal. 87(2). 1298–1306. 70 indexed citations
5.
Kureishi, A, Jonathan Diver, Brenda Beckthold, Tineke Schollaardt, & L E Bryan. (1994). Cloning and nucleotide sequence of Pseudomonas aeruginosa DNA gyrase gyrA gene from strain PAO1 and quinolone-resistant clinical isolates. Antimicrobial Agents and Chemotherapy. 38(9). 1944–1952. 100 indexed citations
6.
Diver, Jonathan, Tineke Schollaardt, Harvey Rabin, Chad M. Thorson, & L E Bryan. (1991). Persistence mechanisms in Pseudomonas aeruginosa from cystic fibrosis patients undergoing ciprofloxacin therapy. Antimicrobial Agents and Chemotherapy. 35(8). 1538–1546. 25 indexed citations
7.
Diver, Jonathan, Laura J. V. Piddock, & Robert A. Wise. (1990). The accumulation of five quinolone antibacterial agents by Escherichia coli. Journal of Antimicrobial Chemotherapy. 25(3). 319–333. 42 indexed citations
8.
Diver, Jonathan, et al.. (1990). Transformation of Pseudomonas aeruginosa by electroporation. Analytical Biochemistry. 189(1). 75–79. 56 indexed citations
9.
Piddock, Laura J. V., et al.. (1990). Correlation of quinolone MIC and inhibition of DNA, RNA, and protein synthesis and induction of the SOS response in Escherichia coli. Antimicrobial Agents and Chemotherapy. 34(12). 2331–2336. 61 indexed citations
10.
Matthews, Mary J., et al.. (1989). LHRH analogues in the treatment of cancer. Cancer Treatment Reviews. 16(3). 161–175. 10 indexed citations
11.
Diver, Jonathan. (1989). Quinolone Uptake by Bacteria and Bacterial Killing. Clinical Infectious Diseases. 11(Supplement_5). S941–S946. 16 indexed citations
12.
Piddock, Laura J. V., J. M. Andrews, Jonathan Diver, & Robert A. Wise. (1986). In vitro studies of S-25930 and S-25932, two new 4-quinolones. European Journal of Clinical Microbiology & Infectious Diseases. 5(3). 303–310. 6 indexed citations
13.
Piddock, Laura J. V., Jonathan Diver, & Robert A. Wise. (1986). Cross-resistance of nalidixic acid resistantEnterobacteriaceae to new quinolones and other antimicrobials. European Journal of Clinical Microbiology & Infectious Diseases. 5(4). 411–415. 8 indexed citations
14.
Diver, Jonathan & Robert A. Wise. (1986). Morphological and biochemical changes in Escherichia coli after exposure to ciprofloxacin. Journal of Antimicrobial Chemotherapy. 18(Supplement_D). 31–41. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lisa M. Leung Breakdown of academic impact, for papers by Anne-Marie Girard Breakdown of academic impact, for papers by Svetlana Dubiley Breakdown of academic impact, for papers by Asha S. Nayar Breakdown of academic impact, for papers by Miguel A. Alcantar Breakdown of academic impact, for papers by Lorenz Brandstätter Breakdown of academic impact, for papers by Indran Mathavan Breakdown of academic impact, for papers by Nathan Haseley Breakdown of academic impact, for papers by Christopher E. Morgan Breakdown of academic impact, for papers by Christine Sizemore
Rankless by CCL
2026